Evaluation of the Hepatotoxic Potential of Minocycline
Overview
Authors
Affiliations
Minocycline (25 to 100 micrograms/g) dose dependently increased serum glutamic oxalacetic transaminase, urea, and bilirubin levels, and the hepatic triglyceride content in mice. In animals pretreated with phenobarbital to enhance minocycline metabolism, the effects on liver triglycerides were attenuated, while the changes in serum glutamic oxalacetic transaminase, urea, and bilirubin were enhanced. It is concluded that part of the toxic effects of minocycline may be produced by a metabolite of minocycline.
Neuroinflammation in hepatic encephalopathy: mechanistic aspects.
Jayakumar A, Rao K, Norenberg M J Clin Exp Hepatol. 2015; 5(Suppl 1):S21-8.
PMID: 26041953 PMC: 4442850. DOI: 10.1016/j.jceh.2014.07.006.
Kholmukhamedov A, Czerny C, Hu J, Schwartz J, Zhong Z, Lemasters J Shock. 2014; 42(3):256-63.
PMID: 24978888 PMC: 4134396. DOI: 10.1097/SHK.0000000000000213.
Ferretti M, Allard S, Partridge V, Ducatenzeiler A, Cuello A J Neuroinflammation. 2012; 9:62.
PMID: 22472085 PMC: 3352127. DOI: 10.1186/1742-2094-9-62.
Bastos L, de Oliveira A, Watkins L, Moraes M, Coelho M Naunyn Schmiedebergs Arch Pharmacol. 2012; 385(3):225-41.
PMID: 22282331 DOI: 10.1007/s00210-012-0727-1.
DiCenzo R, Peterson D, Cruttenden K, Mariuz P, Rezk N, Hochreiter J Antimicrob Agents Chemother. 2008; 52(9):3035-9.
PMID: 18573930 PMC: 2533492. DOI: 10.1128/AAC.00194-08.